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 1 
Glial cells influence cardiac permittivity as evidenced through in vitro and in silico models 1 
 2 
Jonathan R. Soucy, Jody Askaryan, David Diaz, Abigail N. Koppes, Nasim Annabi, Ryan A. 3 
Koppes 4 
Keywords: Tissue Engineering, electrophysiology, Heart, Gap Junctions, Computational 5 
Modeling, In Vitro Modeling, Microphysiological systems; GelMA; Schwann cells; 6 
Cardiomyocytes; organs-on-chip; excitation-contraction coupling 7 
Abstract 8 
Excitation-contraction (EC) coupling in the heart has, until recently, been solely accredited to 9 
cardiomyocytes. The inherent complexities of the heart make it difficult to examine non-muscle 10 
contributions to contraction in vivo, and conventional in vitro models fail to capture multiple 11 
features and cellular heterogeneity of the myocardium. Here, we report on the development of a 12 
3D cardiac µTissue to investigate changes in the cellular composition of native myocardium in 13 
vitro. Cells are encapsulated within micropatterned gelatin-based hydrogels formed via visible 14 
light photocrosslinking. This system enables spatial control of the microarchitecture, perturbation 15 
of the cellular composition, and functional measures of EC coupling via video microscopy and a 16 
custom algorithm to quantify beat frequency and degree of coordination. To demonstrate the 17 
robustness of these tools and evaluate the impact of altered cell population densities on cardiac 18 
µTissues, contractility and cell morphology were assessed with the inclusion of exogenous non-19 
myelinating Schwann cells (SCs). Results demonstrate that the addition of exogenous SCs alter 20 
cardiomyocyte EC, profoundly inhibiting the response to electrical pacing. Computational 21 
modeling of connexin-mediated coupling suggests that SCs impact cardiomyocyte resting 22 
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 2 
potential and rectification following depolarization. Cardiac µTissues hold potential for examining 1 
the role of cellular heterogeneity in heart health, pathologies, and cellular therapies.  2 
 3 
  4 
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Ischemic heart disease remains a leading cause of death worldwide. While pharmacological 1 
interventions have improved life expectancy by mitigating key risk factors, therapeutic strategies 2 
for repairing the damaged myocardium have yet to become the clinical standard (Björnson et al., 3 
2016; Hashimoto et al., 2018). Following infarct, delivery of autologous cells, including 4 
mesenchymal stem cells, cardiac stem cells, and endothelial progenitor cells, have yielded 5 
promising results at the benchtop, but inconsistent benefits in clinical trials (Hatzistergos and 6 
Vedenko, 2017; Malliaras and Marbán, 2011; Muller et al., 2018; Tang et al., 2018). To improve 7 
the efficacy of potential therapeutic strategies, new experimental models at the benchtop that 8 
enhance our fundamental understanding of the contribution of cardiac support cells are required. 9 
 10 
In a healthy heart, cardiomyocytes (CMs) are the most abundant cells by volume, but only make 11 
up 25-35% of the total myocardial cells (Pawlak et al., 2018; Perbellini et al., 2018; Pinto et al., 12 
2016; Skelly et al., 2018; Zhou and Pu, 2016). While the percentage of CMs in the heart is 13 
relatively accepted, there is a lack of consensus regarding the interstitial cell composition in the 14 
heart (Pinto et al., 2016). Current perspectives suggest the presence of fibroblasts, endothelial cells, 15 
smooth muscle cells, pericytes, Schwann cells (SCs), macrophages, telocytes stem cells, 16 
conduction cells (pacemaker cells and Purkinje fibers), neurons, and atrial and ventricular CMs 17 
(Armour, 1991; Gherghiceanu and Popescu, 2012; Nandi and Mishra, 2015; Pawlak et al., 2018; 18 
Perbellini et al., 2018; Pinto et al., 2016; Popescu et al., 2015; Skelly et al., 2018; Xin et al., 2013; 19 
Zhou and Pu, 2016). Further, the role of electric-coupling of resident, non-myocyte cells such as 20 
fibroblasts (Sachse et al., 2008), macrophages (Hulsmans et al., 2017), telocytes (Sheng et al., 21 
2014), and stem cells (Mayourian et al., 2016) has only recently been observed and modeled. Due 22 
to current experimental limitations, the investigation of these cell types and their interactions 23 
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 4 
require a combination of in vivo, in vitro, and in silico examination. Not only is the composition 1 
of the heart diverse, but an accurate understanding of cellular interactions is critical to fully 2 
comprehend cardiac pathogenesis and aid the development of new therapeutic strategies (Iseoka 3 
et al., 2018; Pinto et al., 2016; Zamani et al., 2018).  4 
 5 
The development of robust and biomimetic in vitro models recapitulating key features of 6 
mesoscale architecture and heterogeneity of in vivo counterparts is essential for the study of 7 
fundamental biological processes. While traditional two-dimensional (2D) cell culture techniques 8 
have been used for decades and contributed greatly to the understanding of cardiomyocyte 9 
function, limitations such as atypical cell size and morphology, de-differentiation, and limited cell-10 
cell contacts limit discovery (Natarajan et al., 2011; Zuppinger, 2016). Three-dimensional (3D) 11 
cell culture has helped to overcome some of these limitations by providing more physiologically 12 
relevant microenvironments, imparting robust mechanical cues as well as intra- and extra-cellular 13 
adhesion complexes similar to native tissue (Li et al., 2012; Ravi et al., 2015; Zuppinger, 2019). 14 
In typical 3D culture, cells are encapsulated within extracellular matrix (ECM) like materials to 15 
more closely mimic the in vivo tissue architecture (Gonzalez-Diaz and Varghese, 2016; Tibbitt 16 
and Anseth, 2009). However, current 3D culture models are often limited to simple geometries or 17 
require the use of complex and expensive microfabrication techniques or microfluidics to form 18 
more complex biomimetic 3D constructs. Cell printing has enabled the production of complex 3D 19 
structures in vitro (Mandrycky et al., 2016), however, the shear forces that cell experience during 20 
processing have greatly precluded the use of sensitive cell types like CMs (Kacarevic et al., 2018; 21 
Mitcheson et al., 1998). 22 
 23 
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Photocrosslinkable hydrogels facilitate an alternative to 3D printing by patterning complex shapes 1 
and structures to recapitulate in vivo architecture of tissues including the heart (DeForest et al., 2 
2009; Yue et al., 2015). However, the reliance on ultraviolet (UV) light in these systems may lead 3 
to reduced cell viability (Naseer et al., 2017; Noshadi et al., 2017a). Further, while 4 
photocrosslinkable materials are relatively inexpensive to synthesize, the specialized light sources 5 
required to polymerize the materials are prohibitively expensive for widespread use. More 6 
specifically, there are no in vitro models to investigate the impact of resident non-CM cells on 7 
cardiomyocyte function. Therefore, there remains a need to develop an alternative inexpensive 8 
approach for designing an in vitro 3D culture model that can be scaled to systematically examine 9 
the multicellular nature of the cardiovascular system. 10 
 11 
To address these challenges, here, we describe the development of a biomimetic, 3D in vitro model 12 
(or cardiac µTissue) to examine the role of different cell types in the heart. Specially, primary 13 
cardiac cells were encapsulated at different ratios and variable geometries to assess the importance 14 
and function of SCs and the potential influence on local alignment. Previously, the role of SCs in 15 
the myocardium has remained difficult to assess in vivo as knock-out models are unviable due to 16 
abnormal cardiac development during embryogenesis (Barik et al., 2016; Lee et al., 1995; Morris 17 
et al., 1999). Therefore, to better mimic the cardiac microenvironment and maintain CM phenotype 18 
in vitro (Saini et al., 2015; Wanjare and Huang, 2017), a photolithography technique was used to 19 
create cardiac μTissues of micropatterned gelatin methacrylate (GelMA) via an inexpensive visible 20 
light LED (405 nm) system. Cardiac µTissue functional output was evaluated on a cell-by-cell 21 
basis using a novel algorithm to measure beats per minute (BPM) as well as the degree of 22 
coordination (DoC). In addition, functional differences between visible and traditional UV light 23 
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 6 
photocrosslinking systems for encapsulation were compared in patterned and unpatterned systems. 1 
As a proof of concept for the potential of these cardiac µTissues to study cardiovascular health and 2 
repair, the role of exogenous SC incorporation, an abundant cell type whose function in the heart 3 
remains unknown, was characterized (Fig. 1A). Lastly, a computational model of SC-CM coupling 4 
was developed to provide deeper insight into the underlying SC impact on CM electrophysiology. 5 
 6 
Experimental Procedures 7 
2.1 GelMA synthesis and hydrogel fabrication. GelMA, derived from fish gelatin, was synthesized 8 
as previously reported(Nichol et al., 2010). In brief, 8% (v/v) methacrylic anhydride (Sigma) was 9 
added to a 10% (w/v) fish gelatin (Sigma) solution in Dulbecco’s Phosphate Buffered Saline 10 
(DPBS, Sigma). The product of this reaction was dialyzed (Spectra/Por 12-14kD, Fisher Scientific) 11 
using distilled water for 1 week, and then lyophilized for use on demand. GelMA hydrogel 12 
precursor solutions (7.5% (w/v)) were prepared in complete culture medium [Dulbecco's Modified 13 
Eagle Medium (DMEM) without phenol red (Sigma) supplemented with 10% fetal bovine serum 14 
(Sigma), 2 mM L-glutamine (Gibco), and 50 units/mL penicillin/streptomycin (Gibco)] with 0.5% 15 
(w/v) 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (Irgacure® 2959, CIBA 16 
Chemicals) or 0.5% lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP, Biobots) as 17 
photoinitiators. Hydrogel precursors were then photocrosslinked by exposure to UV light (365 nm) 18 
with an Omnicure S2000 (Excelitas Technologies) for Irgacure® containing precursor hydrogels 19 
or visible light (405 nm) with a 10W LED (QUANS) for LAP containing precursor hydrogels 20 
(0.25 seconds of 10 mW/cm2 light exposure per µm of hydrogel thickness). 21 
 22 
Page 6 of 38AUTHOR SUBMITTED MANUSCRIPT - BF-102006.R2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Ac
ce
pte
d M
an
us
c i
pt
 7 
2.2 Mechanical characterization. The compressive modulus of each hydrogel formulation (5%, 1 
10%, and 15% (w/v) polymer concentration for UV and visible light crosslinked hydrogels) was 2 
examined using an ElectroForce mechanical load frame (TA instruments) with a 1000 gr load cell. 3 
Hydrogel samples were prepared in custom polydimethylsiloxane (Sylgard) molds (cylinders of 6 4 
mm diameter; 4 mm height). Hydrogels were loaded between two compression platens, and cyclic 5 
uniaxial compression tests were conducted at 0.5 Hz (10 cycles). Compression displacement and 6 
load for each cycle were recorded using WinTest7 software. The compressive modulus was 7 
calculated as the tangent slope of the linear region of the stress-strain curves between 0.1 – 0.25 8 
stain level. Three independently prepared samples for each formulation were measured to quantify 9 
the compressive modulus. 10 
 11 
2.3 Primary cardiac cell isolation. Primary CMs and adherent cardiac cells (aCCs) were isolated 12 
from two-day old (p2) Sprague-Dawley neonatal rat (Charles River) hearts, following a modified 13 
protocol by Noshadi et al. (Noshadi et al., 2017b) and approved by Northeastern’s Institutional 14 
Animal Care and Use Committee (IACUC). In brief, the thorax was opened and the heart was 15 
removed. The major veins and atria were then removed so that only the left and right ventricles 16 
remained. The ventricles were cut into 3-4 pieces and stored in 0.05% (v/v) trypsin (Gibco) in 17 
Hank’s balanced salt solution (HBSS, Gibco) at 4 °C with continuous shaking overnight. The 18 
following day, the ventricle pieces were removed from the trypsin and subject to sequential 19 
collagenase treatments (305 units Collagenase II (Gibco) in HBSS) at 37 °C to dissociate the 20 
connective tissue and collect cardiac cells. Cells were then filtered through a 70-µm cell strainer 21 
(Falcon) and pre-plated in a tissue culture flask (T-175, Corning) with complete culture medium 22 
to enrich the CM population by differential adhesion. After one hour in standard cell culture 23 
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 8 
conditions (37 °C, 5% CO2), any unattached cells were considered to be CMs, while those attached 1 
cells were deemed aCCs. Each cell population was then counted and used for experimentation 2 
within one hour following completion of the pre-plating enrichment. 3 
 4 
2.4 SCs isolation. Primary SCs were isolated from p2 Sprague-Dawley neonatal rat sciatic nerves 5 
using established protocols (Koppes et al., 2014; Soucy et al., 2018). Sciatic nerves were harvested 6 
and kept in complete culture medium on ice for a maximum of 4 h. Dissected nerves were minced 7 
into 1-2 mm pieces under sterile conditions and incubated in a 6-well plate using complete culture 8 
medium in standard conditions. Tissue were then transferred to a new dish after visual 9 
confirmation of fibroblast migration. Three to four days after SC migration, cells were cultured 10 
with complete medium supplemented with 10−5 M cytosine arabinoside (Sigma) for 72 h to remove 11 
remaining highly mitotic fibroblasts. Next, a complement-mediated cell lysis was used to eliminate 12 
remaining fibroblasts. Cells were detached with 0.25% (v/v) trypsin/EDTA (Corning) and pelleted 13 
at 200 g for 5 min. Fibroblasts were targeted by re-suspending in 1 mL anti-CD90/Thy 1.1 (diluted 14 
1:500 v/v in DMEM, Cedar Lane Labs) and incubated under standard conditions for 30 min. 15 
Treated cells were pelleted, re-suspended in 1 mL rabbit complement, and incubated for 30 min 16 
with standard conditions to selectively lyse the fibroblasts. After incubation, cells were 17 
centrifuged, re-suspended in SC maintenance medium (complete medium supplemented with 6.6 18 
mM forskolin (Sigma) and 10 µg mL−1 bovine pituitary extract (Corning)), and cultured in a flask 19 
for expansion. Lysis was repeated if fibroblast impurities remained. SC purity was assessed using 20 
anti S-100 (DAKO). Maintenance medium was changed every other day and SCs were passaged 21 
before 100% confluency until P10. 22 
 23 
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2.5 3D cell encapsulation. Equal parts of enriched CMs and aCCs (1:1), or CMs, aCCs, and SCs 1 
(1:1:1), were mixed with the hydrogel precursor solution (7.5% GelMA (w/v) and 0.5% (w/v) 2 
Irgacure® or LAP) at a density of 1.5x107 cells/mL. Approximately 10 µL cell-laden gel precursor 3 
solution was placed between a 180 µm-tall spacer and a 3-(trimethoxysilyl) propyl methacrylate 4 
(ACROS Organics) coated glass slide, followed by 45 seconds (10mW/cm2) light exposure 5 
through a laser cut black cardstock paper photomask (500 µm lines) to form patterned cell-laden 6 
hydrogels. Samples were incubated for 10 days in standard culture conditions with medium 7 
replaced every other day. Cell viability within 3D cardiac µTissues was determined via a 8 
LIVE/DEAD® viability/cytotoxicity kit (Life Technologies) one day post encapsulation. 9 
 10 
2.7 Cardiac beating quantification. Individual CM contractions within the 3D µTissues were 11 
quantified with a custom MATLAB (Mathworks) code to calculate beats per minute (BPM) on a 12 
cell-by-cell basis using video microscopy. Cardiac cells were recorded at 30 frames per second 13 
with phase contrast on a Zeiss Axio Observer at 20x with an incubation chamber (37°C and 5% 14 
CO2). Raw video files were exported as AVIs (M-JPEG compression, 90% quality) and imported 15 
into MATLAB for analysis. Regions of interest (ROIs) were identified from the first frame of the 16 
video recording as objects between 75 μm2 – 1000 μm2 in size (Figure S1A). To quantify BPM, 17 
the sum differences in frame-to-frame pixel intensity were measured for each ROI. Inclusion 18 
criteria for a beating CM was: 1) peak amplitude was greater than one standard deviation above 19 
the mean, 2) negative spikes were less than two standard deviations below the mean, and 3) the 20 
frequency of spikes was below 6 Hz (Figure S1B-C). After passing these prerequisites, beating 21 
was recorded as the number of spikes found in inclusion criteria 1. However, for high frame rate 22 
movies (frames per second > 10), both CM contraction and relaxation may result in recorded spikes 23 
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 10 
(Figure S1D). To record only a single beat per contraction, the mean inter-spike-interval was 1 
calculated for each cell and spikes occurring below this value were disregarded. The average BPM 2 
was then calculated as the mean number of contractions for all ROIs in field of view (m > 20) 3 
multiplied by 60 and divided by the video length from a minimum of three samples per condition 4 
(n > 3).  5 
 6 
To validate of accuracy and precision of this algorithm for measuring CM beating, simultaneous 7 
video microscopy (Axio Examiner at 40x) and electrical potential via a multielectrode array 8 
(MEA, multichannel systems) recordings were acquired and compared. Timestamps for each 9 
contraction from the identified CMs were assigned a unique identification number to gather a 10 
quantification on the degree of coordinated contraction in the µTissue models. Specifically, 11 
timestamped contraction data was imported into a modified algorithm originally developed to 12 
investigate neuronal activity (Kreuz et al., 2015), and values of one minus the SPIKE-distance, an 13 
estimator of the similarity between spike trains, were reported as a means to quantify degree of 14 
coordinated CM contractions. 15 
 16 
2.8 External electrical pacing. Electrical pacing of CMs was assessed using a chamber designed 17 
to apply pulsatile electrical stimuli(Tandon et al., 2009) (50% duty square waves) to patterned cell-18 
laden hydrogels at increasing frequencies (0.5, 1, 2, and 3 Hz) and voltage (1, 3, and 5 V) for 30 19 
s. Alternating electrical stimulation was applied via two carbon rod electrodes mounted in a glass 20 
petri dish 2 cm apart. Pulsatile electrical signals were applied using a function generator (Agilent) 21 
connected to each carbon electrode with platinum wires. Alternating current stimulation was 22 
implemented to minimize hydrolysis. The chamber was filled with complete medium and each 23 
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 11 
cell-laden hydrogel µTissue was aligned along the axis of the applied electric field between the 1 
two electrodes. The battery of conditions was randomized across samples to negate influence of 2 
testing order, and a minimum of five samples were examined at all frequencies and voltages. 3 
 4 
2.9 Immunocytochemistry. Cell-laden µTissues were fixed with 4% paraformaldehyde (30 min), 5 
permeabilized with 0.1% X-100 Triton (20 min), then blocked with 5% goat serum (>12 h) in 6 
DPBS. After overnight blocking, samples were incubated in 1:400 rabbit anti S-100 (DAKO, 7 
Z0311), 1:200 mouse anti sarcomeric α-actinin (Abcam, ab9465), mouse anti CD90, and/or 1:200 8 
goat anti connexin-43 (Abcam, ab87645) in blocking solution overnight at 4 ºC. Cell-laden 9 
hydrogels were then washed thrice with DPBS and anti-rabbit, anti-mouse, and anti-goat 10 
secondary antibodies (1:200 in goat serum) were added overnight at 4 ºC. Samples were rinsed 11 
with DPBS and mounted on cover slides with ProLong® Gold Antifade with 4',6-diamidino-2-12 
phenylindole (DAPI). Lastly, the constructs were imaged using an inverted fluorescence 13 
microscope (Zeiss Axio Observer Z1). 14 
 15 
2.10 Computational model of SC-CM Coupling. SC electrophysiological properties were 16 
mathematically simulated by curve fitting published voltage clamp data to a Hodgkin-Huxley 17 
model using MATLAB. Specifically, type I potassium (Baker and Ritchie, 1996), L-type calcium 18 
(Amédée et al., 1991), and the sodium currents (Howe and Ritchie, 1990) were incorporated into 19 
this model. The electrophysiology properties of a beating cardiomyocyte coupled to a SC was 20 
modeled as previously described (Sachse et al., 2008). Model parameters are expanded upon in 21 
Supplementary Information. 22 
 23 
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2.11 Statistical analysis. All data was first determined to be normally distributed using the 1 
Lilliefors test in MATLAB. Normally distributed data was compared in MATLAB by using a 2 
student-t test for data sets containing only two experimental conditions (Figure 6D), a one-way 3 
ANOVA for experiments with more than two conditions (Figures 1C, 2E, 4C, and 6A-B), and a 4 
multi-way ANOVA for comparisons across multiple days (Figures 3 and Fig. 5A-B). Non-5 
normally distributed data was compared in MATLAB with the Kruskal-Wallis test (Figure 5G). 6 
A minimum of three images from three independent samples were analyzed to quantify viability, 7 
aspect ratio, and total cell percentage. Error bars represent the mean ± standard deviation of 8 
measurements (**p < 0.05). 9 
 10 
Results 11 
Cardiac Tissue Models 12 
3D cardiac cultures were developed to rapidly and inexpensively synthesize µTissues. GelMA 13 
hydrogels were crosslinked with either a UV or visible light photoinitiator system: Irgacure® using 14 
an Omnicure S2000 (365 nm) or LAP using a custom 405nm LED system (Figure S2A). The 15 
compressive modulus of the visible crosslinked hydrogels increased significantly from 1.16 ± 0.04 16 
kPa for 5% (w/v) GelMA to 22.56 ± 1.91 kPa for 10% GelMA to 80.49 ± 2.75 kPa for 15% GelMA 17 
(Figure S2B). Based on these data, a 7.5% (w/v) GelMA hydrogel was selected to best mimic the 18 
stiffness of the native cardiac tissue (mean 6.8 kPa) (Bhana et al., 2010).  19 
 20 
Primary cardiac cells were encapsulated in patterned (500 µm wide lines; 2 mm separation) 21 
GelMA hydrogels by controlling the areas of the precursor hydrogel that were exposed to light 22 
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using laser cut black cardstock paper (Figure 1B). 3D μTissues exhibited increased viability 1 
(93.44 ± 3.75) compared to constructs formed with UV light, irrespective of the photoinitiator 2 
(Figures 1C and S3). This method was used to fabricate a range of 3D geometries conventionally 3 
only achievable using microfluidics or bioprinting (Figure 1D). Further, by adjusting the height 4 
of spacers from 180 µm to 360 or 540 µm, we demonstrated the ability to form a range of µTissue 5 
thicknesses as well as assembling layers of different compositions (Figure 1E). However, despite 6 
our ability to increase µTissue thickness, a nutrient diffusion limitation would exist for hydrogels 7 
> 300 µm that may significantly decrease CM viability (Figueiredo et al., 2018; Lovett et al., 2009; 8 
Sawyer et al., 2018). 9 
 10 
3.2 Functional Characterization of Cardiac Output 11 
To overcome the challenges associated with recording electrical potentials in 3D cultures as well 12 
as mitigate the financial hurdle of electrophysiology equipment, video microscopy has been used 13 
to measure cardiac frequency (Annabi et al., 2013; Huebsch et al., 2015; Saini et al., 2015). 14 
However, this method does not account for the DoC between CM contractions, an important 15 
indicator of myocardium maturity. To determine isolated vs. conducted contraction in our 3D 16 
µTissues, we developed an automated MATLAB algorithm to measure both CM BPM and DoC. 17 
Individual cells were identified within 3D μTissues (Figure 2A) and classified as beating or a non-18 
beating cardiac cells based upon inclusion criteria (i.e., signal-to-noise ratio, peak-to-peak 19 
frequency; Figure 2B). The summation was used to calculate the global BPM for each 20 
experimental condition.  21 
 22 
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The DoC was quantified by assigning each beating CM with a unique cell ID# and plotting the 1 
timestamp of each contraction (Figure 2C). To quantify DoC, these plots were analyzed with a 2 
SPIKE algorithm developed for assessing synchrony in neuron populations (Kreuz et al., 2015). 3 
As shown in Figure 2D, quantified cell beating using our developed algorithm has a one-to-one 4 
correlation with recordings processed using a MEA, demonstrating the robustness of our image 5 
analysis tool and that we are detecting CM depolarization (Supplemental Video 1). As further 6 
validation, μTissues were treated with isoproterenol, a beta-adrenergic agonist to demonstrate the 7 
utility of this algorithm to detect a changes in physiological responses (Maoz et al., 2017). A 8 
temporal increase in beating frequency (~50%) and decrease in DoC (~10%) was detectable with 9 
this video quantification tool (Figure 2E). 10 
 11 
3.3 Impact of Patterning and Photoinitiator on 3D µTissues 12 
Spontaneous beating was recorded over a period of 9 days for cardiac μTissue constructs formed 13 
across all hydrogel samples. Similar to previous findings (Saini et al., 2015), no beating was 14 
observed when only enriched populations of CMs were encapsulated within the 3D µTissues (data 15 
not shown). µTissues crosslinked with visible light (LAP), on average, exhibited on average a 25% 16 
increase in rates of beating for all measured time points compared to Irgacure® controls (Figure 17 
3A-C). There were no differences in the DoC were apparent when comparing crosslinking systems 18 
irrespective of patterning (Figure 3B-C). However, regardless of the crosslinking system 19 
implored, the inclusion of aCCs within patterned hydrogels led to spontaneous beating on day 3 20 
post encapsulation vs. day 4 post encapsulation for unpatterned samples (Figures 3A and 3D). 21 
Lastly, despite the relatively low CM density, patterned 3D µTissues exhibited a statistically 22 
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significant (p < 0.0001) increase in DoC compared to unpatterned hydrogels throughout the entire 1 
study (Figure 3E-F).  2 
 3 
3.4 SC incorporation in the 3D µTissues  4 
To validate the use of cardiac µTissues for further understanding the role of non-myocyte support 5 
cells in the heart, CM functional outputs and morphological differences were assessed with the 6 
inclusion of exogenous SCs. Enriched CM and aCC populations were characterized via 7 
immunocytochemistry to quantify the endogenous cell composition as a baseline of isolation 8 
heterogeneity. As expected, an increased ratio of CMs, identified by sarcomeric  a-actinin, were 9 
present in the enriched CM suspension (Figure 4A-C). The remaining non-adherent (enriched CM 10 
suspension) and adherent (aCCs) cells were identified by staining for fibroblasts (CD90+), smooth 11 
muscle cells (α-smooth muscle actin+), and SCs (S100+). While, immunostaining demonstrated 12 
that both the enriched CM and aCC cultures contained heterogeneous cell populations, this 13 
analysis only provides a glimpse of all the cells found in the heart (Gherghiceanu and Popescu, 14 
2012; Nandi and Mishra, 2015; Pinto et al., 2016; Popescu et al., 2015; Zhou and Pu, 2016). 15 
However, by the reincorporation of all cell collected from the cardiac dissociation, the cardiac 16 
µTissues better recapitulate the cellular composition of an intact myocardium. The proportion of 17 
viable S100+ cells isolated from the heart was 19.61 ± 4.08%, which is approximately double of 18 
the SC composition previously reported for the human atria (Popescu et al., 2015). This higher 19 
than expected value, in part, may be due to false positives, specifically S100 expression in 20 
macrophages (Hulsmans et al., 2017). 21 
 22 
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Injected SCs have demonstrated therapeutic effects on cardiac function following infarction in 1 
rodent models (Wang et al., 2012; Zhang et al., 2010). Here, SCs from the sciatic nerve were used 2 
to ensure a high concentration and avoid a potential loss of phenotype that has previously been 3 
reported for cardiac support cells during expansion (Zuppinger, 2016). Inclusion of SCs led to a 4 
significant 2-fold increase (p < 0.0001) in the BPM of CMs as compared to controls at all measured 5 
time points (Figure 5A, Figure S4, Supplemental Video 2-3). Additionally, the inclusion of SCs 6 
decreased the DoC from 85.10 ± 0.98% to 76.76 ± 0.99% (Figure 5B). These trends were also 7 
observed for cardiac cells with/without SCs when cultured on a 2D scaffold (Figure S5). There 8 
were no observable morphological differences of CMs within the µTissues after the incorporation 9 
of SCs (Figure 5C-D), yet in 2D cultures, CMs co-cultured with SCs possessed an aspect ratio of 10 
4.1 ± 1.8 compared to 1.6 ± 0.5 for controls without SCs (Figure 5E-G).  11 
 12 
3.5 Electrical Pacing of 3D µTissues 13 
Electrical stimulation (ES) to pace the 3D µTissues provided better understand how SCs may 14 
influence contraction of the myocardium. ES was applied on day 5 post encapsulation via carbon 15 
rod electrodes as previously reported (Tandon et al., 2009). BPM were measured for different 16 
frequencies and voltages of applied ES. Prior to ES, encapsulated cardiac cells had an average 17 
BPM of 45.27 ± 2.16. Ramping from 1V to 3V to 5V led to an increased response that trended 18 
toward the applied frequency for 2 (117.19 ± 8.85) and 3 Hz (153.11 ± 6.95) at 5V (Figure 6A). 19 
The cardiac µTissues were unable to be paced at 0.5 or 1 Hz for any of the tested voltages. As the 20 
rate of spontaneous beating was close to the 1 Hz pacing, the effects of electrical stimulation in 21 
this range were indeterminable. The incorporation of SCs into these constructs (average BPM of 22 
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60.50 ± 9.51) completely prevented electrical pacing at any of the tested frequencies and voltages 1 
(Figure 6B). Immunocytochemistry of the co-culture suggests that SCs ability to insulate CMs 2 
may in part be due to the formation of connexin junctions between SCs and CMs (Figure 6C). 3 
Lastly, with the addition of a connexin blocker, heptanol, a small percentage of CMs exhibited 4 
increased beat rates when electrically stimulated (Figure 6D), which were visually identified 5 
following slight increases in averaged beat rate with heptanol treatment (data not shown).  6 
 7 
3.6 Modeling of CM-SC Coupling 8 
As evidence by visual analysis of 3D µTissues contractility, SCs influenced the 9 
electrophysiological properties of CMs in vitro. To further explore this interaction, we modeled 10 
CM-SC coupling in silico (Figure 6E). We first developed a simple SC model by fitting published 11 
SC voltage clamp data for a type I potassium channel (Baker and Ritchie, 1996), a L-type calcium 12 
channel (Amédée et al., 1991), and a sodium channel (Howe and Ritchie, 1990). Equations for 13 
maximum current, channel conductance, activation and inactivate coefficients, and time constants 14 
vs. membrane potential were used to simulate voltage clamp experiments for each SC channel 15 
(Figure S6-8). Coupling the simulated SC to a CM model in silico (Sachse et al., 2008) suggested 16 
that SCs increase the CM resting potential and accelerates repolarization (Figure 6F-H). In vivo, 17 
a decreased action potential duration for 90% repolarization (APD90) increases the frequency at 18 
which a CM can be depolarized (Hulsmans et al., 2017), thereby increasing the maximum beating 19 
frequency. However, contrary to our results from electrical pacing, a higher resting potential did 20 
not reduce the stimulation threshold necessary to facilitate depolarization.  21 
 22 
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Discussion 1 
Our developed biomimetic in vitro 3D µTissues hold potential to measure functional outputs as 2 
cardiac cellular composition is manipulated. This system approaches the resolution of cell printing 3 
without subjecting sensitive primary CMs to the temperatures and shear stresses often associated 4 
with bioprinting conditions (Blaeser et al., 2016). GelMA allows tunability to mimic native 5 
mechanics, possesses protein composition to native myocardium ECM as well as a high 6 
availability of cell binding domains, and can be processed into 3D geometries (Yue et al., 2015). 7 
But, traditional GelMA crosslinking requires high intensity UV and cytotoxic photoinitiators (Yue 8 
et al., 2015) motivating the development of visible light crosslinking systems (Annabi et al., 2017; 9 
Fairbanks et al., 2009; Noshadi et al., 2017a; Yue et al., 2015).  10 
 11 
EosinY/Triethanolamine is a type II photoinitiator that supports cell viability for encapsulated 3T3 12 
fibroblasts (Noshadi et al., 2017a), but poor viability for primary CMs (Noshadi et al., 2017b) in 13 
crosslinked GelMA hydrogels. Type II photoinitiators also require longer photocrosslinking 14 
exposure times to achieve the same mechanical properties as type I photoinitiators (Fairbanks et 15 
al., 2009), increasing free radicals that can impact viability (Maxwell and Lip, 1997). However, in 16 
addition to the photocytotoxicity, Irgacure®, the most common type I photoinitiator used for 17 
crosslinking GelMA, is by itself cytotoxic (Fairbanks et al., 2009). Therefore, we investigated the 18 
use of LAP, a commercially available visible light type I photoinitiation, for the development of 19 
our cardiac µTissues. GelMA hydrogels formed with either photoinitiator (LAP and Irgacure®) 20 
exhibited similar mechanical properties (Figure S2B), within the ranges (~1 – 80 kPa) previously 21 
reported (Yue et al., 2015). Primary cardiac cells encapsulated in GelMA hydrogels using LAP 22 
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and visible light possessed higher cell viability than those formed by using UV light and/or 1 
Irgacure® (Figure 1C), as reported previously in other cells (Fairbanks et al., 2009).  2 
 3 
Correlating in-the-dish measures of contractility to cardiac output and health is paramount for the 4 
long-term utility of in vitro cardiac models. BPM, DoC, and conduction velocity have been 5 
exclusively measured electrically (Natarajan et al., 2011). However, methods for intra and 6 
extracellular recordings require expensive equipment, specialized expertise, and use of these 7 
techniques with 3D µTissues provides additional technical challenges, such as reduced signal-to-8 
noise ratios, low-throughput, and cell damage during the penetration of glass electrodes into the 9 
3D µTissues (Tonomura et al., 2010). Attempts to overcome these limitations have yielded some 10 
success by measuring contractions via video microscopy (Annabi et al., 2013; Huebsch et al., 11 
2015; Saini et al., 2015) or cantilevers (Boudou et al., 2012; Morimoto et al., 2013; Uzel et al., 12 
2016). In each of these cases, beating frequency is measured by counting the global changes in 13 
intensity, size, and/or force measurements over a set duration. These techniques fail to directly 14 
measure variability across individual beating cells, thus quantification of coordination and 15 
conduction velocity remain out of reach. Here, we developed a custom processing technique that 16 
allows for cardiac function to be assessed on a per cell basis that renders comparable results to 17 
traditional electrophysiology (Figure 2). Further, due to our non-destructive imaging of cardiac 18 
beating, this approach may be used in combination with the previously mentioned techniques to 19 
correlate macroscopic function to intracellular interactions in both 2D and 3D culture systems. Our 20 
algorithm is capable of calculating conduction velocity, but accurate measures rely on frame rates 21 
faster than 200 frames per second to determine differences between cells, speeds which lies beyond 22 
the capabilities of most camera systems.  23 
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 1 
Towards investigating the effects of cardiac architecture, the role of patterning was assessed as an 2 
approach to improve function, specifically DoC. Maintaining coordinated beating in the heart is 3 
required in vivo to pump blood throughout the body, thus DoC is a critical metric to quantify for 4 
the establishment of cardiac μTissues. Previous studies have suggested local CM alignment is 5 
required to support synchronous beating and can be improved with micropatterned features having 6 
widths less than 100 µm (Saini et al., 2015; Salick et al., 2014). Here, to study the sole impact of 7 
mesoscale architecture on DoC, μTissues were developed with widths of 500 µm. As expected, 8 
there was no improved local, cellular alignment within patterned cardiac μTissues, but alignment 9 
of the cell-laden substrate resulted in an increase in DoC. Therefore, despite not exhibiting an 10 
alignment of CM along a single axis, patterned cardiac μTissues possess a higher degree of 11 
functionality towards recapitulating the native myocardium.  12 
 13 
To understand how SCs might affect cardiomyocyte phenotype, we incorporated both primary SC 14 
and CM into µTissues. SCs are non-neural support cells that play an essential role in neuron 15 
signaling and regeneration (Armati and Mathey, 2013). SCs have been evaluated at the bench as a 16 
cell therapy for cardiac failure (Wang et al., 2012; Zhang et al., 2010) and make up a substantial 17 
composition of the heart (Gherghiceanu and Popescu, 2012; Popescu et al., 2015). Often cells 18 
isolated from the heart are characterized as either CMs or cardiac FBs (Annabi et al., 2016; Annabi 19 
et al., 2013; Noshadi et al., 2017a; Noshadi et al., 2017b; Saini et al., 2015; Shin et al., 2016), but 20 
in fact these populations are heterogeneous and contain fewer than 20% FBs. For this reason, we 21 
established a new nomenclature for this cell isolation protocol in which suspension cells are 22 
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referred to as enriched CMs and the adherent cells are referred to as adherent cardiac cells (aCCs). 1 
Further, the presence of these aCCs is critical for developing functional engineered cardiac tissues 2 
from stem cells (Iseoka et al., 2018).  3 
 4 
CMs co-cultured with SCs in standard 2D conditions exhibited an increased aspect ratio (between 5 
5 and 9.5; Figure 5A-C), typical of a more mature CM phenotype (Denning et al., 2016). 6 
Qualitatively, CMs cultured with SCs present with more clearly defined z-disks, evidenced by 7 
localization of a-actinin, elongation of nuclei, and a possible an increase in bi-nucleation (Figure 8 
S9): indicators of CM differentiation and maturation (Scuderi and Butcher, 2017; Zebrowski et al., 9 
2017). In response to peripheral nerve damage, non-myelinating SCs provide topographical cues 10 
that influence the rate and direction of neurite outgrowth (Hoffman-Kim et al., 2010), with 11 
monolayers of SCs exhibiting beneficial local alignment that impacts sensory neuron growth in 12 
vitro (Seggio et al., 2010). CMs may exhibit a higher aspect ratio via similar structural cues. 13 
Peculiar to this observation of increased CM differentiation, the presence of exogenous SCs 14 
increased the average BPM as well as a decrease the DoC in cardiac µTissues (Figure 5F-G), 15 
similar to higher BPM observed during development (Lindsey et al., 2014). However, 16 
immunofluorescent images of the CMs within the cardiac µTissues containing exogenous SCs did 17 
exhibit the higher aspect ratios observed in 2D cultures (Figure 5C-D). Within a 3D scaffold, the 18 
mechanical microenvironment, specifically the increase in cell-ECM adhesions, may limit the 19 
influence of SC structure on CM morphology. Additionally, SC proliferation rate may be slowed 20 
(Edmondson et al., 2014), limiting the density of SCs to promote local CM alignment. In addition 21 
to providing guidance cues, SCs also overexpress matrix metalloproteinases (MMPs) following a 22 
nerve injury (Liu et al., 2010; Parrinello et al., 2010). Therefore, due to an abundance of MMP-23 
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sensitive degradation sequences in gelatin (Vandooren et al., 2013), the inclusion of SCs may alter 1 
the mechanical properties of our µTissues over time, which may also influence cardiac phenotype 2 
and contraction (Bhana et al., 2010). This reduction in mechanical stability was confirmed 3 
observationally by the increase degradation and delamination of the µTissues from the glass slides 4 
after 9 days (Figure S10). Nevertheless, similar contractile trends were observed when cells were 5 
cultured on 2D scaffolds compared to those cultured in 3D, ruling out confounding effects of 6 
material degradation (Figure S5). 7 
 8 
Developing mammalian hearts beat at higher rates due a higher ratio of connective tissue to muscle 9 
or aCCs to CMs, immature T-tubule and sarcoplasmic reticulum, and a higher concentration of 10 
plasma calcium (Louch et al., 2015). CM contraction is predominantly regulated by intracellular 11 
Ca2+ concentration cycling and a resultant membrane depolarization, that in mature CM constructs 12 
originates with an atrial pacemaker and progresses to surrounding cells with a high DoC. Non-13 
myelinating SCs exhibit excitable properties including regulating Ca2+ in neuromuscular junctions 14 
(Reist and Smith, 1992) and K+ in the axonal microenvironment (Robert and Jirounek, 1994). 15 
While SC presence in the heart has recently been highlighted, their role on plasma and cytosol ion 16 
dynamics in the myocardium remains unknown. 17 
 18 
When external electrical stimulation was applied to 3D µTissues, SCs prevented the CMs within 19 
the µTissues from being externally paced. Similarly, Zhang et al. reported that the injection of 20 
exogenous SCs into the heart reduced the occurrence of electrically induced arrhythmias (Zhang 21 
et al., 2010). We hypothesize that SCs, which are known to express connexin proteins (Nicholson 22 
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and Bruzzone, 1997), form connexin junctions with some CMs (Figure 6C), therefore increasing 1 
the resting potential and allowing for a more rapid depolarization and subsequent contraction and 2 
expansion. This mechanism of CMs forming connexin junctions with other cells is demonstrated 3 
by a recent report in which cardiac macrophages are shown to increase the CM resting potential 4 
(Hulsmans et al., 2017). While SCs maintain a higher resting membrane potential compared to 5 
CMs (-40 mV for SCs (Baker and Ritchie, 1996; Howe and Ritchie, 1990) vs. -80 mV for CMs 6 
(Sachse et al., 2008)), SCs also contain ion channels for Ca2+ and Na+ in addition to similar K+ 7 
channels to those in cardiac macrophages. Therefore, it is expected that in addition to an increased 8 
resting potential, the CM electrophysiological properties will be significantly altered by SC 9 
coupling.  10 
 11 
Executing a CM-SC in silico model revealed that the initial depolarization of the SC membrane 12 
with CM depolarization led to an overcorrection to repolarize the SC membrane, which helped to 13 
quicken the CM repolarization. However, with increased coupling, the rate at which a CM is 14 
repolarized returned to its initial APD90, thereby suggesting an enhanced ability for CMs coupled 15 
with SCs to better regulate their membrane potential, while initial resting potential continues to 16 
increase. Lastly, when treated with a general connexin blocker, heptanol (Brokamp et al., 2012), a 17 
small percentage of CMs responded to external, pulsatile electrical stimulus while non-blocked 18 
SC-CM cultures did not (Figure 6D). These cells were visually identified and analyzed. While the 19 
proximity of these identified CMs to SCs was not known during live video recordings, this finding 20 
may support SCs ability to electrically couple to CMs via gap junctions, similar to that observed 21 
with fibroblasts (Sachse et al., 2008) and macrophages (Hulsmans et al., 2017). However, the 22 
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mechanism which leads to increased beating and diminished coordination requires further 1 
investigation.  2 
 3 
In conclusion, our 3D µTissues provide a cardiac cell-supporting microenvironment by better 4 
mimicking the function and cellular composition of the heart, which is critical for the development 5 
of cell and tissue engineering therapeutic strategies (Cimetta et al., 2013). Furthermore, this 6 
platform can be exploited to investigate the multicellular composition of the heart via the inclusion 7 
of exogenous cell populations. Specially, utilizing this approach in combination with 8 
computational modeling, we demonstrated that SCs may play a critical role in CM maturation and 9 
as electrical insulators in the heart. This system may provide a means to model human physiology 10 
and pathology through the incorporation of stem cell derived cardiac cell populations. All together, 11 
these approaches in conjunction with computational models, quantitative cardiac outputs, and low 12 
capital expensive will hopefully lead to a more widespread use of microphysiological systems, 13 
which can be utilized to increase translation of novel therapies to the clinic. All algorithms for both 14 
analysis and modeling can downloaded from http://www.northeastern.edu/lnnr.  15 
  16 
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 5 
 6 
Figures 7 
 8 
Figure 1. Cardiac μTissue development. (A) Schematic representation of the in vitro co-culture 9 
system to investigate the heterogeneity of the myocardium. (B) Schematic of photopatterning 10 
hydrogels using visible light. (C) Quantification of live/dead images show >90% cardiac cell 11 
viability in GelMA crosslinked using LAP with visible light (** p < 0.05). IRG: Irgacure® 2959. 12 
LAP: phenyl-2,4,6-trimethylbenzoylphosphinate. (D) Representative images demonstrating an 13 
ability to photopattern a range of geometries (scale = 1000 μm) and (E) heights, including layers 14 
of different compositions, as shown by cross-sections of the 3D μTissues (scale = 100 μm). 15 
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 1 
Figure 2. Cardiac beating quantification via video microcopy. (A) Representative bright field 2 
image with automated identification of encapsulated cells (scale = 200 μm). (B) Representative 3 
plots showing the change pixel intensity over time for both a beating and non-beating cell. (C) 4 
Representative spike train analog used to quantify the degree of coordinated contractions (green = 5 
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high level of synchrony, red = some semblance synchrony, blue = no apparent synchrony). (D) 1 
Validation of beating quantification shows a one-for-one correlation with electrophysiology 2 
recordings. (E) Isoproterenol treatment of encapsulated cardiac cells shows an expected increase 3 
in beat rate and a decrease in synchrony measured via video microcopy (** p < 0.05). 4 
 5 
Figure 3. Model development informed by cardiac output quantification. (A) Quantification 6 
of beat rate for cardiac cells encapsulated in unpatterned and patterned hydrogels over time using 7 
a UV (Irgacure® and 365 nm) or (B) a visible (LAP and 405 nm) or crosslinking system. (C) 8 
Multi-way ANOVA showing statistical differences between the visible and UV crosslinking 9 
systems for beat rate, but not coordination. (D) Quantification of DoC for cardiac cells 10 
encapsulated in patterned or unpatterned hydrogels formed using a UV (Irgacure® and 365nm) or 11 
(E) visible light (LAP and 405nm) crosslinking system. (F) Multi-way ANOVA showing 12 
statistical differences between patterned and unpatterned samples for beating coordination, but not 13 
beat rate. 14 
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Figure 4. Immunofluorescent quantification of cardiac cellular composition. (A) 2 
Representative suspension and (B) adherent cultures grown on fibronectin coated cover slides for 3 
12-18h post tissue dissociation. Cells were stained for markers for cardiomyocytes, sarcomeric 4 
alpha-actinin (red), fibroblast, CD90 (yellow), smooth muscle cells, alpha smooth muscle actin 5 
(cyan), Schwann cells, S100 (green) and cell nuclei, DAPI (blue). (C) Quantification of 6 
immunofluorescent images show that the suspension culture contains an enriched population of 7 
cardiomyocytes, with no statistical differences been other cell populations examined. (** p < 0.05, 8 
ns: not significant p > 0.05) 9 
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Figure 5. Role of SCs in the 2D and 3D cardiac cell cultures. (A) Quantification of BPM and 2 
(B) DoC for 3D μTissues over time showing that the inclusions of SCs leads to an increase and 3 
beat rate and decrease in coordinated contractions. (C) Representative immunofluorescent images 4 
of cardiac cells culture without and (D) with the inclusion of exogenous SCs encapsulated in 3D 5 
μTissues. (E) Representative immunofluorescent images of cardiac cells culture without and (F) 6 
with the inclusion of exogenous SCs in 2D (scale = 100 μm) and (G) CM aspect ratio quantification 7 
(** p < 0.05). 8 
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Figure 6. External electrical pacing of 3D μTissues and computational modeling on CM-SC 1 
coupling. (A) Cardiomyocyte response to electrical stimuli at 0.5, 1, 2, and 3 Hz with increasing 2 
voltages from 1V to 3V to 5V shows cardiac μTissues can be paced (** p < 0.05), but (B) the 3 
inclusion of SCs prevents this electrical pacing (dashed line shows the average beat rate prior to 4 
electrical stimulation). (C) Representative immunofluorescent image showing the presence of 5 
connexin43 (Cx43) junctions (purple) between CMs (red) and SCs (green) (scale = 100 μm, inlay 6 
scale = 10 μm). White arrows indicate Cx43 positive staining at the interface of SCs and CMs. (D) 7 
Electrical pacing at 2Hz and 5V of individual CMs with exogenous SCs following heptanol 8 
treatment to block CM-SC coupling (** p < 0.05). These data represent CM beating from the same 9 
user identified cells before and after heptanol blocking (n = 5). (E) Schematic of a Hodgkin-Huxley 10 
model for CM-SC coupling. (F) Computational model of CM depolarization for one CM coupled 11 
to increasing numbers of SCs overplayed with a coupled SC membrane potential. (G) Changes in 12 
CM membrane potential and (H) APD90 with increased SC coupling. 13 
 14 
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